Cardiovascular conditions occur at an especially high rate among male breast cancer patients, according to new findings presented as part of the American College of Cardiology’s Advancing the Cardiovascular Care of the Oncology…

Atrial fibrillation (AFib) ablation is an effective treatment option for patients with hypertrophic cardiomyopathy (HCM), according to new findings published in the Journal of the American Heart Association.…

Sudden cardiac death (SCD) is more common during nighttime hours for women than men, according to new research out of Cedars-Sinai Medical Center.

SCD, when a disturbance of…

Drinking even a small amount of alcohol can increase a person’s risk of atrial fibrillation (AFib), according to new research published in European Heart Journal.

Tracking…

Patients with atrial fibrillation (AFib) who are treated with non‐vitamin K antagonist oral anticoagulants (NOACs) are less likely to develop diabetes than those treated with warfarin, according to an in-depth analysis out of…

The American College of Cardiology (ACC) is celebrating the holiday season with a new gift for cardiologists: antithrombotic therapy recommendations for patients with atherosclerotic cardiovascular disease (ASCVD) and…

Royal Philips has acquired BioTelemetry, a Pennsylvania-based healthcare technology company focused on remote cardiac diagnostics and monitoring, for $2.8 billion.

BioTelemetry was…

Patients with heart rhythm disorders are not more likely to get COVID-19. The ongoing pandemic has been stressful, however, and anyone with such a disorder may…

Immune checkpoint inhibitor (ICI) therapy is a popular, effective treatment for a variety of cancers. However, according to a new analysis in European Heart Journal, some patients undergoing ICI therapy may face an…

The American College of Cardiology (ACC) and American Heart Association (AHA) have released updated performance measures for treating atrial fibrillation (AFib) or atrial flutter.

…

Researchers have developed a brand new prediction model capable of identifying patients at a heightened risk of atrial fibrillation (AFib), sharing their findings published in Circulation: Arrhythmia and Electrophysiology…

Overdose-related cardiac arrests skyrocketed in the United States during the first months of the COVID-19 pandemic, according to a new analysis in JAMA Psychiatry.

The…

There are no benefits to treating patients with hydroxychloroquine after they have already been exposed to COVID-19, according to a new study published in the New England Journal of Medicine.

Drinking too much alcohol in a given week can put atrial fibrillation (AFib) patients at an increased risk of stroke, embolism and other significant health issues, according to new findings published in EP Europace.…

A significant number of atrial fibrillation (AFib) patients who are referred for ablation have undiagnosed sleep apnea, according to a new study published in JACC: Clinical Electrophysiology. …

Tommy Sweeney, a professional football player for the Buffalo Bills, has developed myocarditis as a side effect of a recent COVID-19 diagnosis and will miss the rest of the 2020 season.

…

Atrial fibrillation (AFib) increases the likelihood that aortic stenosis (AS) patients will experience in-hospital complications, according to new findings published in the American Journal of Cardiology. This appears…

Drug therapy is typically recommended for the initial treatment of patients with atrial fibrillation (AFib), but should physicians consider starting off with catheter ablation instead?

…

Contrary to previous reports, omega-3 fatty acids and vitamin D3 supplements do not prevent the development of atrial fibrillation (AFib), according to new findings presented at the American Heart…

Hospitalized COVID-19 patients with abnormal heart rhythms may be susceptible to “markedly worse outcomes,” according to new data to be presented at the American Heart Association’s Scientific Sessions 2020 virtual meeting.…

Long-term anticoagulation is a safe stroke prevention strategy for atrial fibrillation (AFib) patients 90 years old and older, according to new findings published in the American Journal of Cardiology. …